Formulytica will be participating in the Australian Association of Regulatory and Clinical Scientists (ARCS) 2023 Annual Conference. This event for the pharmaceutical, biotech, and medical technology sector is scheduled to take place from June 6th to June 8th at the International Convention Centre in Darling Harbour, Sydney.
The ARCS Annual Conference brings together industry professionals, consumers, patients, practitioners, researchers, and academia to facilitate education, information sharing, and networking. With a program featuring over 85 sessions and seven concurrent streams per day, the conference covers cutting-edge topics, vital regulatory changes, and emerging trends. Participants will have the opportunity to contribute to discussions that shape the industry’s future, while receiving the latest updates on regulatory and clinical guidance.
Formulytica’s presence at the conference will allow us to showcase our expertise in pharmaceutical formulation development, particularly in clinical trial supply and the creation of high quality, innovative clinical-ready formulations. Our company’s strong track record in supporting clients from early formulation development through manufacturing and product launch, with the support of patents, demonstrates the vital role we play in the early life cycle of prescription, over the counter, and personal care products.
The conference anticipates more than 1,500 delegates, including professionals from industry, academia, and government. We look forward to meeting many old and new faces at Formulytica’s booth.